327 related articles for article (PubMed ID: 23179142)
1. Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia.
Leeuwenburgh I; Scholten P; Caljé TJ; Vaessen RJ; Tilanus HW; Hansen BE; Kuipers EJ
Dig Dis Sci; 2013 Jan; 58(1):244-52. PubMed ID: 23179142
[TBL] [Abstract][Full Text] [Related]
2. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
[TBL] [Abstract][Full Text] [Related]
3. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus].
Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G
Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403
[TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus and achalasia.
Guo JP; Gilman PB; Thomas RM; Fisher RS; Parkman HP
J Clin Gastroenterol; 2002 Apr; 34(4):439-43. PubMed ID: 11907357
[TBL] [Abstract][Full Text] [Related]
6. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
7. Esophageal adenocarcinoma in a patient with surgically treated achalasia.
Goodman P; Scott LD; Verani RR; Berggreen CC
Dig Dis Sci; 1990 Dec; 35(12):1549-52. PubMed ID: 2253539
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus after cardiomyotomy for esophageal achalasia.
Jaakkola A; Reinikainen P; Ovaska J; Isolauri J
Am J Gastroenterol; 1994 Feb; 89(2):165-9. PubMed ID: 8304296
[TBL] [Abstract][Full Text] [Related]
10. Esophageal achalasia and adenocarcinoma in Barrett's esophagus: a report of two cases and a review of the literature.
Ellis FH; Gibb SP; Balogh K; Schwaber JR
Dis Esophagus; 1997 Jan; 10(1):55-60. PubMed ID: 9079276
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma.
Doorakkers E; Lagergren J; Santoni G; Engstrand L; Brusselaers N
Helicobacter; 2020 Jun; 25(3):e12688. PubMed ID: 32175626
[TBL] [Abstract][Full Text] [Related]
12. Barrett's metaplasia and dysplasia in postmyotomy achalasia patients.
Feczko PJ; Ma CK; Halpert RD; Batra SK
Am J Gastroenterol; 1983 May; 78(5):265-8. PubMed ID: 6846301
[TBL] [Abstract][Full Text] [Related]
13. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
[TBL] [Abstract][Full Text] [Related]
14. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
15. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.
Tofani CJ; Gandhi K; Spataro J; Yoo J; Murphy M; Mohan N; Daitch Z; Shah A; Janowski R; Huntley C; Dabbish N; Keith S; Coben R; Cohen S; Kastenberg D; Infantolino A
United European Gastroenterol J; 2019 Mar; 7(2):225-229. PubMed ID: 31080607
[TBL] [Abstract][Full Text] [Related]
16. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
17. Incidence of GERD, esophagitis, Barrett's esophagus, and esophageal adenocarcinoma after bariatric surgery.
Bevilacqua LA; Obeid NR; Yang J; Zhu C; Altieri MS; Spaniolas K; Pryor AD
Surg Obes Relat Dis; 2020 Nov; 16(11):1828-1836. PubMed ID: 32711954
[TBL] [Abstract][Full Text] [Related]
18. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus and achalasia. A case report.
Lee FI; Bellary SV
J Clin Gastroenterol; 1991 Oct; 13(5):559-61. PubMed ID: 1744394
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma and Barrett's esophagus following surgically treated achalasia.
Shah AN; Gunby TC
Gastrointest Endosc; 1984 Oct; 30(5):294-6. PubMed ID: 6489712
[No Abstract] [Full Text] [Related]
[Next] [New Search]
